However, we think LGALS3 only has limited auxiliary diagnostic ability due to emerging molecular markers, such as IDH mutation, 1p/19q codeletion, and BRAF-KIAA1549 fusion (pilocytic astrocytoma's characteristic molecular alteration). This evidence concerns the gene LGALS3 and pilocytic astrocytoma.